Equity Overview
Price & Market Data
Price: $0.432
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $419,915,309
Daily Volume: 0
Performance Metrics
1 Week: -13.52%
1 Month: -4.57%
3 Months: 5.28%
6 Months: 5.28%
1 Year: 188.3%
YTD: -4.57%
About Hua Medicine (Shanghai) Ltd. (HUMDF)
Financial insights into Hua Medicine (Shanghai) Ltd. (HUMDF). Current price: 0.432, daily change: $0.00 / 0.00%. Market cap: 419,915,309. Performance metrics across all timeframes are updated.
Company Details
Employees: 328
Sector: Health technology
Industry: Pharmaceuticals: major
Country: China
Details
Hua Medicine (Shanghai) Ltd. engages in the development and commercialization of drugs for the treatment of diabetes in China. The company develops HuaTangNing (Dorzagliatin or HMS5552), an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D and DKD. It also provides Dorzagliatin in combination with GLP1RA for T2D and obesity; in combination with insulin to treat Type 1 Diabetes; second generation glucokinase (GK) inhibitor for metabolic disease; mGLUR5 negative allosteric modulator (NAM) for PD-LID and drug addiction; and GK NAM for metabolic disease. Hua Medicine (Shanghai) Ltd. was incorporated in 2011 and is based in Shanghai, China.